mmpc-logo
twitter-logo @NationalMMPC
| Create Account | login
Publication
Development of a novel murine model of lymphatic metastasis.
Authors Banan B, Beckstead JA, Dunavant LE, Sohn Y, Adcock JM, Nomura S, Abumrad N,
Goldenring JR, Fingleton B
Submitted By Submitted Externally on 9/28/2020
Status Published
Journal Clinical & experimental metastasis
Year 2020
Date Published 4/1/2020
Volume : Pages 37 : 247 - 255
PubMed Reference 32052231
Abstract Current laboratory models of lymphatic metastasis generally require either
genetically modified animals or are technically challenging. Herein, we have
developed a robust protocol for the induction of intralymphatic metastasis in
wild-type mice with reproducible outcomes. To determine an optimal injection
quantity and timeline for tumorigenesis, C57Bl/6 mice were injected directly
into the mesenteric lymph duct (MLD) with varying numbers of syngeneic murine
colon cancer cells (MC38) or gastric cancer cells (YTN16) expressing
GFP/luciferase and monitored over 2-4 weeks. Tumor growth was tracked via
whole-animal in vivo bioluminescence imaging (IVIS). Our data indicate that the
injection of tumor cells into the MLD is a viable model for lymphatic metastasis
as necropsies revealed large tumor burdens and metastasis in regional lymph
nodes. This protocol enables a closer study of the role of lymphatics in cancer
metastasis and opens a window for the development of novel approaches for
treatment of metastatic diseases.





Menu

Home
Contact
About MMPC
Animal Husbandry
Tests Data
Search Data
Analysis
Clients
MMPC Centers

Newsletter

Interested in receiving MMPC News?
twitter-logo Mouse Phenotyping
@NationalMMPC



2017 National MMPC. All Rights Reserved.